Glimpse the technologies that will catapult neurosurgery to the next level of precision.
How David Julius and Ardem Patapoutian found the molecules in our bodies that sense heat, cold, touch, and pain – and transformed sensory neuroscience.How David Julius and Ardem Patapoutian found the molecules in our bodies that sense heat, cold, touch, and pain – and transformed sensory neuroscience.
Fragmented Tau in Diseased Neurons Also Presents New Target for Existing DrugsIn a new study of Alzheimer’s disease, UCSF reserachers have discovered that a relatively unstudied form of the tau protein associated with neurodegeneration may be a means for better diagnosis and treatment of the disease.
Patients Show Elevated Levels of Viral and Nerve-Cell ProteinsIn a new study of long COVID, UCSF researchers identified biomarkers present at elevated levels that may persist for many months in the blood of study participants who had long COVID with neuropsychiatric symptoms.
After an age-related spinal injury suddenly worsened, Angie Jacobson could barely stand or walk. She chose to undergo an "awake spine surgery" at UCSF, leaving the hospital less than 24 hours later.
‘CEO of the Brain’ Focuses Attention on the Most Relevant Stimuli in the EnvironmentWhen exploring a new environment, mice make use of a unique long-distance connection in the brain that prompts them to pay attention to the most salient features of the environment, according to new UCSF research.
D’Anne Duncan is the first black woman to deliver the UCSF Last Lecture, which she gave during a live event on April 6, answering the question “If you have but one lecture to give, what would you say?”
For 29 years, Rashetta Higgins was wracked by epileptic seizures. UCSF neurologists used a pioneering imaging technique to spot what was triggering them and then removed that region from her brain. Now Rashetta is living a seizure-free life.
A Q&A with UCSF neurologist William Seeley, MDIn a study, UCSF neurologist William Seeley, MD, and colleagues identified two key moments in the natural history of Alzheimer’s, pointing to a window of opportunity for treatment with amyloid-lowering drugs.
UCSF Study Shows Aggressive Therapy Is Best for Deadly Tumor Masquerading as Lower-Grade GliomaBrain tumor patients survived longer when treated aggressively with surgery, radiation and chemotherapy. Now, a UCSF study underscores the critical role of genomic profiling in diagnosing and grading brain tumors.